Background: Recently, narrow-band ultraviolet B (NB-UVB) and topical immunomodulators
have been successfully used in the treatment of vitiligo. Objective: To determine whether the …

Vitiligo is an acquired loss of pigmentation and its treatment remains very difficult up to date.
Narrow band ultraviolet B (NB-UVB) and topical immunomodulators are included among the …

Background: Vitiligo is an acquired, pigmentary skin disorder which is disfiguring and
difficult to treat. In an earlier open label study in adult patients with vitiligo, pimecrolimus …

Background: Vitiligo is a chronic disease that mostly affects children and young adults.
Nowadays many treatment options are available; however, most of them have limited …

Objectives: The purpose of this study was to assess the efficacy of pimecrolimus cream 1%
in vitiligo and to evaluate the effects of age of the patients, age of onset and duration of …

Objective: The purpose of this study is to compare the efficacy of three therapies in the
treatment of non-segmental vitiligo: a combination of topical calcipotriol, narrowband …

Vitiligo is a common skin condition resulting from loss of normal melanin pigments in the
skin which produces white patches. Topical corticosteroids are indicated for the treatment of …

Background: Scientific rationale and encouraging first clinical results suggest the interest of
using apremilast for treating vitiligo. Objective: This study aimed to compare the efficacy of …

Summary Background/Purpose Narrow‐band ultraviolet B (NB‐UVB) is considered the most
effective and safe initial treatment for moderate‐to‐severe vitiligo but phototoxicity and …

The current treatment of vitiligo is not satisfactory according to the opinions of both the
patient population and the dermatologists. Recently, combination therapies have been …